secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABVC BIOPHARMA, INC. (ABVC)
CIK:        0001173313
Form:       8-K
Filed at:   2024-08-20T23:59:59+00:00
Accession:  0001213900-24-071145
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ABVC BioPharma updates corporate presentation; no material new details disclosed
--------------------------------------------------------------------------------

- Company filed Form 8-K furnishing an updated corporate presentation on August 20, 2024.
- Filing text and exhibit provide no specific financial data, milestones, or strategic changes.
- No guidance, partnerships, product developments, or other substantive updates revealed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1173313/000121390024071145/0001213900-24-071145-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1173313/000121390024071145/ea0211916-8k_abvc.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-071145

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer